During clinical diabetes trials, researchers discovered that many patients experienced weight loss from taking GLP-1 medication
3 These rates appear higher than those seen with the injection, which may reflect the daily dosing pattern compared with once-weekly injections
Semaglutide may indirectly affect electrolyte levels in several ways: Nausea, vomiting, or diarrhea: These side effects can lead to a loss of important electrolytes, especially potassium and magnesium, which are critical for normal heart rhythm
How Semaglutide May Support Weight Management Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists
This concern is real but often overstated, particularly in people who are insulin sensitive or adapting to fat burning, and it becomes secondary to the muscle preservation imperative when semaglutide is involved